Clinical trial NCT01698151: Prognosis and Treatment of COPD in Primary Care-use of Biomarkers
Official title: Prognosis and Treatment of COPD in Primary Care-use of Biomarkers
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Keywords: Chronic obstructive Pulmonary Disease
COPD
Lead sponsor: University of Southern Denmark
Sponsor class: OTHER
Collaborators: name: The Ministry of Science, Technology and Innovation, Denmark
name: Region of Southern Denmark
First posted: 2012-10-02
Enrollment: 2000
Sex: ALL
Minimum age (years): 40
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients in primary care on the Fyn island, Denmark

Brief summary: This is an observational study in primary care aiming to validate biomarkers for chronic obstructive pulmonary disease (COPD).


Eligibility criteria: Inclusion Criteria:

* 40 years old or more,
* diagnosis of COPD in primary care

Exclusion Criteria:

* Major psychiatric illness,
* inability to visit primary care doctor,
* inability to understand danish language,

Primary outcomes:
measure: Hospitalization
timeFrame: December 1, 2015
Secondary outcomes:
Other outcomes:
Locations:
city: Middelfart
country: Denmark
facility: Nyhegn, Søndergaard, Trabjerg og Vilhelmsen
state: Fyn
city: Odense C
country: Denmark
facility: Peer Kirkebjerg
state: Fyn
city: Odense
country: Denmark
facility: Lægerne J.B. Winsløws Vej
state: Fyn
city: Odense
country: Denmark
facility: Peter Larsen
state: Fyn
city: Otterup
country: Denmark
facility: Lægerne Lærkevej
state: Fyn
city: Søndersø
country: Denmark
facility: Søndersø Lægehus
state: Fyn
city: Aarup
country: Denmark
facility: Aaruplægerne
city: Agedrup
country: Denmark
facility: Lægerne i Bullerup
city: Assens
country: Denmark
facility: Lægehuset Skelvænget
city: Faaborg
country: Denmark
facility: Lægerne Lægehuset
city: Faaborg
country: Denmark
facility: Per Andersen
city: Gislev
country: Denmark
facility: Lægehuset i Gislev
city: Haarby
country: Denmark
facility: Haarbylægerne
city: Haarby
country: Denmark
facility: Jordløselægerne
city: Hesselager
country: Denmark
facility: Lægerne i Hesselager
city: Hesselager
country: Denmark
facility: Lægerne i Hesselager
city: Kerteminde
country: Denmark
facility: Lægerne Glenthøj & Nielsen
city: Kerteminde
country: Denmark
facility: Lægerne Tronegaard-Madsen og Schmidt
city: Kerteminde
country: Denmark
facility: Muusgaarden
city: Kværndrup
country: Denmark
facility: Lægerne i Kværndrup
city: Middelfart
country: Denmark
facility: Lægerne i Havnegade
city: Morud
country: Denmark
facility: Lægehuset i Morud
city: Nyborg
country: Denmark
facility: Lægerne Nr. Voldgade
city: Nyborg
country: Denmark
facility: Lægerne Nyenstad
city: Odense C
country: Denmark
facility: Annette Tornøe
city: Odense C
country: Denmark
facility: Kirsten Wengler
city: Odense C
country: Denmark
facility: Læge Thore Eriksen
city: Odense C
country: Denmark
facility: Lægerne Agertoft og Petersen
city: Odense SØ
country: Denmark
facility: Almen Medicinsk Lægeklinik
city: Odense
country: Denmark
facility: Bylægen Peer Kirkebjerg & Speciallæge Nanna Kirkebjerg
city: Odense
country: Denmark
facility: Læge Bo Gamborg Nielsen
city: Otterup
country: Denmark
facility: Lægerne Banepladsen
city: Ringe
country: Denmark
facility: Lægerne i Østergade
city: Rudkøbing
country: Denmark
facility: Lægehuset Rudkøbing I/S
city: Rudkøbing
country: Denmark
facility: Lægerne Ørstedsgade
city: Svendborg
country: Denmark
facility: Lægerne Toldbodvej
city: Vissenbjerg
country: Denmark
facility: Lægehuset i Vissenbjerg
city: Årslev
country: Denmark
facility: Lægerne i Nr. Lyndelse
Study officials:
affiliation: University of Southern Denmark
name: Frans Boch Waldorff, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Sondergaard J, Halling A. The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care. BMC Pulm Med. 2014 May 20;14:88. doi: 10.1186/1471-2466-14-88.